Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Stock Traders Daily
Provider: Reuters Investment Profile
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA's Animal Health Arm Seals Deal With Dosch Pharmaceuticals Private Ltd-Business Line

Thursday, 13 Jun 2013 08:00pm EDT 

Business Line reported that Sanofi SA's animal health division Merial, sealing a deal in this segment. Merial had formalised an agreement to acquire the animal health division of Dosch Pharmaceuticals Private Ltd in December last year. Merial said, on June 14, 2013, that it had received all regulatory approvals required to close the acquisition. The acquired business, the animal health division of Sanofi Synthelabo India, will commence marketing Dosch’s 86 animal health products and 50 brands for poultry, companion animals and so on, besides continuing the process of registering Merial brands for companion and production animals for commercialisation in India, Sanofi said. Around 270 employees of Dosch are also expected to move into the Merial fold. 

Company Quote

2.41 +2.97%
23 Jan 2015